| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1086072229 |
| P356 | DOI | 10.1023/A:1009066725103 |
| P698 | PubMed publication ID | 10798820 |
| P50 | author | Michael Berk | Q30504747 |
| P2093 | author name string | L Ichim | |
| S Brook | |||
| P433 | issue | 1 | |
| P921 | main subject | lamotrigine | Q410346 |
| P304 | page(s) | 5-10 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Annals of Clinical Psychiatry | Q15716688 |
| P1476 | title | Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial | |
| P478 | volume | 12 |
| Q36560064 | A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder |
| Q39880014 | A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. |
| Q35142739 | Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder |
| Q36836746 | Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran |
| Q57244668 | Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder |
| Q33448290 | Bipolar disorder. |
| Q34387550 | Comparative efficacy and tolerability of drug treatments for bipolar disorder |
| Q37216281 | Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder |
| Q24601815 | Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q34370458 | Emerging options in the treatment of bipolar disorders |
| Q36568973 | How assess drugs in the treatment of acute bipolar mania? |
| Q33518859 | Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. |
| Q36099541 | Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder |
| Q33529314 | Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis |
| Q34340984 | Management of psychiatric disorders in patients infected with human immunodeficiency virus |
| Q36016688 | Managing bipolar disorder in the elderly: defining the role of the newer agents |
| Q46810922 | Mitigating cutaneous side effects of lamotrigine |
| Q34626893 | Mood disorders in patients with epilepsy: epidemiology and management |
| Q34720444 | Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy |
| Q24250164 | Olanzapine alone or in combination for acute mania |
| Q37855777 | Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations |
| Q34508138 | Pharmacologic treatment of geriatric mania |
| Q36130303 | Pharmacotherapy of bipolar mixed states |
| Q44393870 | Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine |
| Q39853694 | Psychiatric Uses of Newer Anticonvulsants |
| Q36648780 | Psychopharmacology of pediatric bipolar disorder: a review |
| Q35645906 | Safety and tolerability of lamotrigine for bipolar disorder |
| Q28066714 | The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm |
| Q36128822 | The management of bipolar disorder in primary care: a review of existing and emerging therapies |
| Q24658110 | The role of lamotrigine in the management of bipolar disorder |
| Q36162402 | Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder |
| Q38647529 | Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study. |
| Q36184726 | Volume and market share of anti-epileptic drugs in The Netherlands: impact of new drugs |
Search more.